Idéal Investisseur
Français English
CAC 40 : Market closed
7 969,42 pts
-0.01%


Last updated : 30/10/2026 - 17h36 (last close)
Last close data

NANOBIOTIX news: financial news, earnings, stock moves and analysts

Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.

The latest financial news on NANOBIOTIX mainly cover share price moves, M&A activity et analyst notes. The stock trades at €28,12 on Euronext Paris, down 7,26% at the last update. This page lists the articles published on NANOBIOTIX stock to track the share price, company announcements and any item likely to influence market perception.

Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
NANOBIOTIX
FR0011341205
Pharmaceuticals & Biotechnology / Biotechnology
28,12 € -7,26 %
High30,60 €
Low28,06 €
Last update : 30/10/2026 - 17:35:25 – Euronext Paris – 15 min delay.
Market closed

Latest NANOBIOTIX stock news

The Paris-based nanomedicine oncology biotech continues a spectacular rebound in a Paris market lacking clear direction. The stock rises above all its…

Nanobiotix presented on October 24, 2026, at the European Society for Medical Oncology (ESMO) Congress in Madrid, the complete results of the melanoma…

The Parisian oncological nanomedicine biotech is advancing at mid-session, bucking the downward trend of the Paris market. This rebound extends a shor…

The Parisian oncological nanomedicine biotech slips slightly in mid-morning trading, in a Paris market clearly oriented downward. This modest pullback…

The Parisian biotech company specializing in oncological nanomedicine rebounded sharply in mid-session, in an SBF 120 oriented upwards. This surge occ…

The Parisian oncological nanomedicine biotech rebounds sharply in mid-afternoon, against the trend of a declining Paris market. This uptick occurs aft…

The Parisian biotech company specializing in oncological nanomedicine is prolonging a decline that has swept away its main technical benchmarks since …

The oncological nanomedicine biotech extends a decline that has been underway for several weeks and is approaching a closely-monitored technical thres…

The Paris-based biotech company specializing in nanomedicine oncology is recovering ground in mid-morning trading, within a rising SBF 120 index. This…

The Paris-based biotech company specializing in nanomedicine for oncology extends its downward slide at midday, in an SBF 120 index itself oriented do…

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA